Purchase Order HHSN263200401290P
- Not listed
- The National Institutes of Health (NIH) awarded a firm fixed-price purchase order valued at $30,000 for scientific studies to be performed in Germany. The contract, awarded on November 19, 2003, was not issued under any set-aside program and carried an ultimate completion date of September 30, 2004. This purchase order structure indicates a straightforward procurement mechanism for defined scientific work, likely supporting NIH's research mission through international collaboration or data...
- <p>The National Human Genome Research Institute, a civilian government agency, awarded a $14,706.15 firm fixed price purchase order contract to Ons Bio LLC for peptide synthesis services. The contract has an ultimate completion date of April 1, 2025 and does not utilize a set-aside designation. As the National Human Genome Research Institute is a component of the National Institutes of Health, this contract likely supports the agency's research mission in genomics and related fields.</p>
- The National Institutes of Health (NIH) awarded a $30,000 firm fixed-price purchase order for scientific studies on December 4, 2003, with an ultimate completion date of September 30, 2004. This civilian contract, which carried no set-aside designation, was performed in Kiribati, a Pacific island nation. The contract structure and modest ceiling value suggest a focused research initiative, likely leveraging NIH's mission to advance medical knowledge and conduct biomedical research across diverse...
- The National Institutes of Health Office of Logistics and Acquisition Operations issued a purchase order to Allama Iqbal Medical Research Centre on May 12, 2017, for DNA collection and analysis services, with a ceiling value of $470,000 under firm fixed price. Performance occurs in Bethesda, Maryland. The order represents Option Year 4 of the underlying DNA collection and analysis services contract, with an ultimate completion date of May 21, 2021. No small business set-aside was applied.
- This federal contract award represents a firm fixed price purchase order valued at $32,096 issued by the National Institutes of Health (NIH) for scientific studies. The contract was awarded on November 5, 2003, with an ultimate completion date of September 30, 2004. No set-aside designation was utilized for this procurement. The work is to be performed at 2323 Riverside Drive, Ottawa, Ontario, Canada, indicating that the prime contractor is a Canadian entity. As a civilian agency within the...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $14,182 purchase order to Carahsoft Technology Corp. to provide telecommunications software and hardware operation, maintenance, and repair services. The single award firm fixed price contract will be performed in Bethesda, Maryland over a one year period concluding in July 2024. No subcontractors or set aside designations were identified. The National Human Genome...
- <p>This is a $5,997.00 firm fixed-price purchase order contract for research services awarded by the National Institutes of Health (NIH), a civilian agency, to an unspecified prime contractor. The contract does not have a set-aside designation and was awarded on May 7, 2005 with an ultimate completion date of May 31, 2005. No further details about the specific research services or any subcontractors are provided.</p>
- <p>This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Inbiomedic Sac, a for-profit limited liability company based in Peru, for $22,771.64 in research services. The contract has a period of performance through November 15, 2025 and does not have a set-aside designation. No additional information about larger contract vehicles or subcontractors is provided.</p>
- The National Institutes of Health National Human Genome Research Institute awarded a $74,250 delivery order to The Johns Hopkins University under an unspecified government-wide acquisition contract. The firm fixed price order is for genotyping services using a global diversity array for genetic research being conducted by NIH's National Institute of Child Health and Human Development. Performance will occur at the prime contractor's Baltimore, Maryland location from September 2023 through...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $10,800 firm fixed price purchase order to Vaccine And Gene Therapy Institute Of Florida Corp. to provide GEN01, Illumina WG BeadChip, Complete 1-Cycle Assay. The place of performance will be in Bethesda, Maryland. The period of performance is from May 14, 2013 through September 30, 2013. No major subcontractors or set aside designations were...
The National Institutes of Health (NIH) awarded a $50,000 firm fixed-price purchase order for gene mapping services effective October 1, 2003, with a completion deadline of September 30, 2004. The contract was awarded without a set-aside designation and will be performed in Pakistan. As a purchase order with a defined ceiling value, this contract represents a direct acquisition of specialized scientific services rather than a competitive solicitation vehicle. Gene mapping services fall within NIH's broader research support functions, which encompass genomic research and bioinformatics capabilities essential to the Institute's mission of advancing medical knowledge and understanding human genetic variation. The relatively modest contract value and overseas performance location suggest this engagement likely involved specialized technical expertise or cost-effective access to genetic analysis capabilities available through international resources, supporting NIH's research objectives while maintaining fiscal efficiency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.0k | 10/20/03 |